Status:

UNKNOWN

Evaluation of The Accuracy of Zygomatico- Maxillary Complex (ZMC) Fractures Reduction Using Patient Specific Guide (PSG) Versus Conventional Technique

Lead Sponsor:

Ahmed Morad

Conditions:

Zygomatic Fractures

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

Evaluation of The Accuracy of Zygomatico- Maxillary Complex (ZMC) Fractures reduction Using Patient Specific Guide (PSG) Versus Conventional Technique

Eligibility Criteria

Inclusion

  • • Zygomatic Fracture Type III, IV and V according to rowe and killey classification(13)
  • Age (18-60 years)
  • Recent fracture (less than 2 weeks)

Exclusion

  • • Zygomatic Fracture Type I, II and VI according to rowe and killey classification(13)
  • Medical compromised patient
  • Patient on radiotherapy
  • Bone disease

Key Trial Info

Start Date :

May 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2022

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT04836130

Start Date

May 1 2021

End Date

June 1 2022

Last Update

April 8 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Evaluation of The Accuracy of Zygomatico- Maxillary Complex (ZMC) Fractures Reduction Using Patient Specific Guide (PSG) Versus Conventional Technique | DecenTrialz